Antitumor Activity of Rat Mesenchymal Stem Cells during Direct or Indirect Co-Culturing with C6 Glioma Cells

Bulletin of Experimental Biology and Medicine
A N GabashviliV P Chehonin

Abstract

The tumor-suppressive effect of rat mesenchymal stem cells against low-differentiated rat C6 glioma cells during their direct and indirect co-culturing and during culturing of C6 glioma cells in the medium conditioned by mesenchymal stem cells was studied in an in vitro experiment. The most pronounced antitumor activity of mesenchymal stem cells was observed during direct co-culturing with C6 glioma cells. The number of live C6 glioma cells during indirect co-culturing and during culturing in conditioned medium was slightly higher than during direct co-culturing, but significantly differed from the control (C6 glioma cells cultured in medium conditioned by C6 glioma cells). The cytotoxic effect of medium conditioned by mesenchymal stem cells was not related to medium depletion by glioma cells during their growth. The medium conditioned by other "non-stem" cells (rat astrocytes and fibroblasts) produced no tumor-suppressive effect. Rat mesenchymal stem cells, similar to rat C6 glioma cells express connexin 43, the main astroglial gap junction protein. During co-culturing, mesenchymal stem cells and glioma C6 cells formed functionally active gap junctions. Gap junction blockade with connexon inhibitor carbenoxolone attenuated the...Continue Reading

References

Nov 9, 2000·Proceedings of the National Academy of Sciences of the United States of America·K S AboodyE Y Snyder
Apr 30, 2003·Cancer Gene Therapy·Vincenza BarresiDaniele Filippo Condorelli
Jan 7, 2004·Journal of Neurosurgery·Wei ZhangWilliam T Couldwell
Mar 11, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Rainer GlassHelmut Kettenmann
May 18, 2007·Progress in Biophysics and Molecular Biology·Jean-Claude HervéHeather S Duffy
Jan 10, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sith SathornsumeteeJeremy N Rich
Aug 2, 2008·The New England Journal of Medicine·Patrick Y Wen, Santosh Kesari
Nov 8, 2008·Annals of the New York Academy of Sciences·Sith Sathornsumetee, Jeremy N Rich
Jul 17, 2009·Acta histochemica·Rosario CaltabianoSalvatore Lanzafame
Jan 11, 2012·Experimental Neurology·Christian SchichorJoerg-Christian Tonn
Jul 18, 2012·Bulletin of Experimental Biology and Medicine·V P BaklaushevV P Chekhonin
Jun 4, 2014·Advances in Cancer Research·Shirin IlkhanizadehAnders I Persson
Jun 20, 2014·Klinická onkologie : casopis Ceské a Slovenské onkologické spolecnosti·P KovaříkováP Bouchal
Aug 30, 2014·Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society·Lucia KucerovaMiroslava Matuskova
Sep 23, 2014·Cell Biochemistry and Biophysics·Liping XuePeng Ding
Jun 3, 2015·Bulletin of Experimental Biology and Medicine·A N GabashviliV P Chekhonin

❮ Previous
Next ❯

Citations

Mar 10, 2018·Chinese Medical Journal·Shuang-Lin DengGang Zhao
Aug 17, 2018·Current Stem Cell Research & Therapy·Mahboobeh RazmkhahAbbas Ghaderi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Astrocytes & Neurodegeneration

Astrocytes are important for the health and function of the central nervous system. When these cells stop functioning properly, either through gain of function or loss of homeostatic controls, neurodegenerative diseases can occur. Here is the latest research on astrocytes and neurodegeneration.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.